Exchange: NASDAQ·Updated 07:30 PM EST

About QURE

About

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
221

Frequently Asked Questions

Advertisement|Remove ads.